Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Interactions between germline variants and somatic mutations is a relatively unexplored topic in cancer. Here, in Ewing sarcoma, the authors show that binding of the oncogenic EWSR1-FLI1 fusion transcription factor to a polymorphic enhancer-like DNA element controls MYBL2, whose high expression corr...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b15283577e6941feafb9a8d8c4019ddd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b15283577e6941feafb9a8d8c4019ddd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b15283577e6941feafb9a8d8c4019ddd2021-12-02T17:01:46ZCooperation of cancer drivers with regulatory germline variants shapes clinical outcomes10.1038/s41467-019-12071-22041-1723https://doaj.org/article/b15283577e6941feafb9a8d8c4019ddd2019-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12071-2https://doaj.org/toc/2041-1723Interactions between germline variants and somatic mutations is a relatively unexplored topic in cancer. Here, in Ewing sarcoma, the authors show that binding of the oncogenic EWSR1-FLI1 fusion transcription factor to a polymorphic enhancer-like DNA element controls MYBL2, whose high expression correlates with prognosis.Julian MusaFlorencia Cidre-AranazMarie-Ming AynaudMartin F. OrthMaximilian M. L. KnottOlivier MirabeauGal MazorMor VaronTilman L. B. HöltingSandrine GrossetêteMoritz GartlgruberDidier SurdezJulia S. GerkeShunya OhmuraAruna MarchettoMarlene DallmayerMichaela C. BaldaufStefanie SteinGiuseppina SanninoJing LiLaura Romero-PérezFrank WestermannWolfgang HartmannUta DirksenMelissa GymrekNathaniel D. AndersonAdam ShlienBarak RotblatThomas KirchnerOlivier DelattreThomas G. P. GrünewaldNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Julian Musa Florencia Cidre-Aranaz Marie-Ming Aynaud Martin F. Orth Maximilian M. L. Knott Olivier Mirabeau Gal Mazor Mor Varon Tilman L. B. Hölting Sandrine Grossetête Moritz Gartlgruber Didier Surdez Julia S. Gerke Shunya Ohmura Aruna Marchetto Marlene Dallmayer Michaela C. Baldauf Stefanie Stein Giuseppina Sannino Jing Li Laura Romero-Pérez Frank Westermann Wolfgang Hartmann Uta Dirksen Melissa Gymrek Nathaniel D. Anderson Adam Shlien Barak Rotblat Thomas Kirchner Olivier Delattre Thomas G. P. Grünewald Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
description |
Interactions between germline variants and somatic mutations is a relatively unexplored topic in cancer. Here, in Ewing sarcoma, the authors show that binding of the oncogenic EWSR1-FLI1 fusion transcription factor to a polymorphic enhancer-like DNA element controls MYBL2, whose high expression correlates with prognosis. |
format |
article |
author |
Julian Musa Florencia Cidre-Aranaz Marie-Ming Aynaud Martin F. Orth Maximilian M. L. Knott Olivier Mirabeau Gal Mazor Mor Varon Tilman L. B. Hölting Sandrine Grossetête Moritz Gartlgruber Didier Surdez Julia S. Gerke Shunya Ohmura Aruna Marchetto Marlene Dallmayer Michaela C. Baldauf Stefanie Stein Giuseppina Sannino Jing Li Laura Romero-Pérez Frank Westermann Wolfgang Hartmann Uta Dirksen Melissa Gymrek Nathaniel D. Anderson Adam Shlien Barak Rotblat Thomas Kirchner Olivier Delattre Thomas G. P. Grünewald |
author_facet |
Julian Musa Florencia Cidre-Aranaz Marie-Ming Aynaud Martin F. Orth Maximilian M. L. Knott Olivier Mirabeau Gal Mazor Mor Varon Tilman L. B. Hölting Sandrine Grossetête Moritz Gartlgruber Didier Surdez Julia S. Gerke Shunya Ohmura Aruna Marchetto Marlene Dallmayer Michaela C. Baldauf Stefanie Stein Giuseppina Sannino Jing Li Laura Romero-Pérez Frank Westermann Wolfgang Hartmann Uta Dirksen Melissa Gymrek Nathaniel D. Anderson Adam Shlien Barak Rotblat Thomas Kirchner Olivier Delattre Thomas G. P. Grünewald |
author_sort |
Julian Musa |
title |
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
title_short |
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
title_full |
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
title_fullStr |
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
title_full_unstemmed |
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
title_sort |
cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/b15283577e6941feafb9a8d8c4019ddd |
work_keys_str_mv |
AT julianmusa cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT florenciacidrearanaz cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT mariemingaynaud cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT martinforth cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT maximilianmlknott cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT oliviermirabeau cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT galmazor cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT morvaron cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT tilmanlbholting cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT sandrinegrossetete cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT moritzgartlgruber cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT didiersurdez cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT juliasgerke cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT shunyaohmura cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT arunamarchetto cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT marlenedallmayer cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT michaelacbaldauf cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT stefaniestein cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT giuseppinasannino cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT jingli cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT lauraromeroperez cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT frankwestermann cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT wolfganghartmann cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT utadirksen cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT melissagymrek cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT nathanieldanderson cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT adamshlien cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT barakrotblat cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT thomaskirchner cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT olivierdelattre cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes AT thomasgpgrunewald cooperationofcancerdriverswithregulatorygermlinevariantsshapesclinicaloutcomes |
_version_ |
1718382046652399616 |